Annual EBIT:
-$338.85M-$116.25M(-52.22%)Summary
- As of today, CRNX annual earnings before interest & taxes is -$338.85 million, with the most recent change of -$116.25 million (-52.22%) on December 31, 2024.
- During the last 3 years, CRNX annual EBIT has fallen by -$231.15 million (-214.62%).
- CRNX annual EBIT is now -5540.05% below its all-time high of -$6.01 million, reached on December 31, 2016.
Performance
CRNX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$129.11M-$17.71M(-15.89%)Summary
- As of today, CRNX quarterly earnings before interest & taxes is -$129.11 million, with the most recent change of -$17.71 million (-15.89%) on June 30, 2025.
- Over the past year, CRNX quarterly EBIT has dropped by -$46.33 million (-55.96%).
- CRNX quarterly EBIT is now -5324.87% below its all-time high of -$2.38 million, reached on September 30, 2017.
Performance
CRNX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$423.06M-$46.33M(-12.30%)Summary
- As of today, CRNX TTM earnings before interest & taxes is -$423.06 million, with the most recent change of -$46.33 million (-12.30%) on June 30, 2025.
- Over the past year, CRNX TTM EBIT has dropped by -$145.11 million (-52.21%).
- CRNX TTM EBIT is now -16146.51% below its all-time high of -$2.60 million, reached on March 31, 2017.
Performance
CRNX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRNX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -52.2% | -56.0% | -52.2% |
| 3Y3 Years | -214.6% | -199.9% | -212.1% |
| 5Y5 Years | -529.5% | -662.7% | -518.7% |
CRNX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -214.6% | at low | -197.1% | at low | -179.8% | at low |
| 5Y | 5-Year | -529.5% | at low | -599.8% | at low | -518.7% | at low |
| All-Time | All-Time | -5540.1% | at low | -5324.9% | at low | >-9999.0% | at low |
CRNX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$129.11M(-15.9%) | -$423.06M(-12.3%) |
| Mar 2025 | - | -$111.41M(-17.6%) | -$376.73M(-11.2%) |
| Dec 2024 | -$338.85M(-52.2%) | -$94.75M(-7.9%) | -$338.85M(-10.5%) |
| Sep 2024 | - | -$87.80M(-6.1%) | -$306.77M(-10.4%) |
| Jun 2024 | - | -$82.78M(-12.6%) | -$277.95M(-12.0%) |
| Mar 2024 | - | -$73.53M(-17.3%) | -$248.16M(-11.5%) |
| Dec 2023 | -$222.61M(-32.6%) | -$62.66M(-6.2%) | -$222.61M(-7.3%) |
| Sep 2023 | - | -$58.98M(-11.3%) | -$207.51M(-8.1%) |
| Jun 2023 | - | -$52.99M(-10.5%) | -$191.98M(-5.5%) |
| Mar 2023 | - | -$47.98M(-0.9%) | -$182.03M(-8.4%) |
| Dec 2022 | -$167.88M(-55.9%) | -$47.56M(-9.4%) | -$167.88M(-11.0%) |
| Sep 2022 | - | -$43.45M(-1.0%) | -$151.21M(-11.5%) |
| Jun 2022 | - | -$43.05M(-27.3%) | -$135.57M(-14.3%) |
| Mar 2022 | - | -$33.83M(-9.5%) | -$118.61M(-10.1%) |
| Dec 2021 | -$107.70M | -$30.89M(-11.1%) | -$107.70M(-9.2%) |
| Sep 2021 | - | -$27.81M(-6.6%) | -$98.61M(-10.5%) |
| Jun 2021 | - | -$26.09M(-13.8%) | -$89.25M(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$22.92M(-5.2%) | -$80.09M(-6.9%) |
| Dec 2020 | -$74.95M(-39.2%) | -$21.79M(-18.1%) | -$74.95M(-9.6%) |
| Sep 2020 | - | -$18.45M(-9.0%) | -$68.38M(-4.9%) |
| Jun 2020 | - | -$16.93M(+4.8%) | -$65.15M(-5.8%) |
| Mar 2020 | - | -$17.78M(-16.9%) | -$61.57M(-14.4%) |
| Dec 2019 | -$53.83M(-87.5%) | -$15.21M(+0.1%) | -$53.83M(-12.0%) |
| Sep 2019 | - | -$15.23M(-14.1%) | -$48.05M(-17.5%) |
| Jun 2019 | - | -$13.35M(-32.9%) | -$40.89M(-23.1%) |
| Mar 2019 | - | -$10.04M(-6.5%) | -$33.23M(-15.7%) |
| Dec 2018 | -$28.71M(-214.6%) | -$9.43M(-16.9%) | -$28.71M(-31.8%) |
| Sep 2018 | - | -$8.07M(-42.0%) | -$21.78M(-35.4%) |
| Jun 2018 | - | -$5.68M(-2.8%) | -$16.09M(-54.6%) |
| Mar 2018 | - | -$5.53M(-121.2%) | -$10.40M(-39.1%) |
| Dec 2017 | -$9.13M(-51.9%) | -$2.50M(-5.0%) | -$7.48M(-50.1%) |
| Sep 2017 | - | -$2.38M(+8.6%) | -$4.98M(-91.4%) |
| Mar 2017 | - | -$2.60M | -$2.60M |
| Dec 2016 | -$6.01M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of CRNX is -$338.85M
What is the all-time high annual EBIT for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$6.01M
What is Crinetics Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, CRNX annual earnings before interest & taxes has changed by -$116.25M (-52.22%)
What is Crinetics Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of CRNX is -$129.11M
What is the all-time high quarterly EBIT for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is -$2.38M
What is Crinetics Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, CRNX quarterly earnings before interest & taxes has changed by -$46.33M (-55.96%)
What is Crinetics Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of CRNX is -$423.06M
What is the all-time high TTM EBIT for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$2.60M
What is Crinetics Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, CRNX TTM earnings before interest & taxes has changed by -$145.11M (-52.21%)